These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 31708925

  • 1. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia.
    Sen-Kilic E, Blackwood CB, Boehm DT, Witt WT, Malkowski AC, Bevere JR, Wong TY, Hall JM, Bradford SD, Varney ME, Damron FH, Barbier M.
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [Abstract] [Full Text] [Related]

  • 2. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous Pseudomonas aeruginosa Strains Based on Expression Profiling of Outer Membrane Proteins During Infection.
    Liu C, Pan X, Xia B, Chen F, Jin Y, Bai F, Priebe G, Cheng Z, Jin S, Wu W.
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [Abstract] [Full Text] [Related]

  • 3. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
    Baker SM, Pociask D, Clements JD, McLachlan JB, Morici LA.
    Vaccine; 2019 Feb 04; 37(6):808-816. PubMed ID: 30638799
    [Abstract] [Full Text] [Related]

  • 4. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
    Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB.
    Infect Immun; 2011 Mar 04; 79(3):1289-99. PubMed ID: 21149583
    [Abstract] [Full Text] [Related]

  • 5. PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
    Schaefers MM, Duan B, Mizrahi B, Lu R, Reznor G, Kohane DS, Priebe GP.
    Vaccine; 2018 Nov 12; 36(46):6926-6932. PubMed ID: 30314911
    [Abstract] [Full Text] [Related]

  • 6. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.
    Wu W, Huang J, Duan B, Traficante DC, Hong H, Risech M, Lory S, Priebe GP.
    Am J Respir Crit Care Med; 2012 Sep 01; 186(5):420-7. PubMed ID: 22723292
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
    Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB.
    Infect Immun; 2011 Aug 01; 79(8):3455-64. PubMed ID: 21628521
    [Abstract] [Full Text] [Related]

  • 8. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A, Owlia P, Siadat SD, Mousavi SF, Ardestani MS, Mohammadpour HK.
    APMIS; 2015 Feb 01; 123(2):175-83. PubMed ID: 25470757
    [Abstract] [Full Text] [Related]

  • 9. Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia.
    Sen-Kilic E, Blackwood CB, Huckaby AB, Horspool AM, Weaver KL, Malkowski AC, Witt WT, Bevere JR, Damron FH, Barbier M.
    Infect Immun; 2021 Jan 19; 89(2):. PubMed ID: 33199354
    [Abstract] [Full Text] [Related]

  • 10. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
    Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB.
    Infect Immun; 2003 Jul 19; 71(7):3875-84. PubMed ID: 12819072
    [Abstract] [Full Text] [Related]

  • 11. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, Goldberg JB, Pier GB.
    J Immunol; 2008 Oct 01; 181(7):4965-75. PubMed ID: 18802100
    [Abstract] [Full Text] [Related]

  • 12. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z, Han D, Sun X, Zhang M, Feng X, Sun C, Gu J, Tong C, Lei L, Han W.
    Appl Microbiol Biotechnol; 2015 Jan 01; 99(2):667-80. PubMed ID: 25381907
    [Abstract] [Full Text] [Related]

  • 13. Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
    Meynet E, Laurin D, Lenormand JL, Camara B, Toussaint B, Le Gouëllec A.
    Vaccine; 2018 Mar 27; 36(14):1893-1900. PubMed ID: 29506924
    [Abstract] [Full Text] [Related]

  • 14. The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia.
    Naito Y, Hamaoka S, Kinoshita M, Kainuma A, Shimizu M, Katoh H, Moriyama K, Ishii KJ, Sawa T.
    Microbiol Immunol; 2018 Dec 27; 62(12):774-785. PubMed ID: 30378708
    [Abstract] [Full Text] [Related]

  • 15. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M, Sun C, Gu J, Yan X, Wang B, Cui Z, Sun X, Tong C, Feng X, Lei L, Han W.
    Microbiol Immunol; 2015 Sep 27; 59(9):533-44. PubMed ID: 26249788
    [Abstract] [Full Text] [Related]

  • 16. Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease.
    Sorichter S, Baumann U, Baumgart A, Walterspacher S, von Specht BU.
    Vaccine; 2009 May 11; 27(21):2755-9. PubMed ID: 19366571
    [Abstract] [Full Text] [Related]

  • 17. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R, El-Naggar W, Abd El-Aziz AM, Shaaban M, Kenawy HI, Ali YM.
    J Microbiol Immunol Infect; 2018 Jun 11; 51(3):312-320. PubMed ID: 28291719
    [Abstract] [Full Text] [Related]

  • 18. Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia.
    Behrouz B, Hashemi FB, Fatemi MJ, Naghavi S, Irajian G, Halabian R, Imani Fooladi AA.
    J Immunol Res; 2017 Jun 11; 2017():5689709. PubMed ID: 29201922
    [Abstract] [Full Text] [Related]

  • 19. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
    Johansen HK, Cryz SJ, Høiby N.
    APMIS; 1994 Jul 11; 102(7):545-53. PubMed ID: 7917224
    [Abstract] [Full Text] [Related]

  • 20. Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.
    Kamei A, Wu W, Traficante DC, Koh AY, Van Rooijen N, Pier GB, Priebe GP.
    J Infect Dis; 2013 Jan 01; 207(1):39-49. PubMed ID: 23100569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.